Reply to The case for catch‐up human papillomavirus vaccination in at‐risk populations: Rural communities and survivors of pediatric and young adult cancers

Abstract

We appreciate the letter from Kacew et al regarding the updated American Cancer Society (ACS) human papillomavirus (HPV) vaccination recommendations,1 which represent an adaption of the recommendations from the Advisory Committee on Immunization Practices (ACIP).2 In particular, Kacew et al take issue with the ACS Guideline Development Group's not endorsing the ACIP's recommendation that adults aged 27 to 45 years who have not been vaccinated should have an opportunity to undergo shared decision making related to catch-up vaccination. Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation. Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement.